{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:40Z","timestamp":1792590160759,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09913-y","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:45:31Z","timestamp":1784954731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Randomised, placebo-controlled study to assess the safety and efficacy of Enterosgel\u00ae in the treatment of functional abdominal pain in children and young people (ENTOPIC): study protocol for a clinical trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Carol A.","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula Velayudhan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Karl\u2010Heinz","family":"Auth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Spray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharamveer","family":"Basude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Markaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radovan","family":"Hnati\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-249X","authenticated-orcid":false,"given":"Stephen J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"9913_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00222-5","volume":"6","author":"N Thapar","year":"2020","unstructured":"Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S, et al. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020;6:89.","journal-title":"Nat Rev Dis Primers"},{"key":"9913_CR2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067677","volume":"155","author":"NK Vermeijden","year":"2025","unstructured":"Vermeijden NK, de Silva L, Manathunga S, Spoolder D, Korterink J, Vlieger A, et al. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. Pediatrics. 2025;155:e2024067677.","journal-title":"Pediatrics"},{"key":"9913_CR3","doi-asserted-by":"crossref","unstructured":"Varni JW, Bendo CB, Nurko S, Shulman RJ, Self MM, Franciosi JP et al. Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Module Testing Study Consortium. Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr. 2015:166:85-90","DOI":"10.1016\/j.jpeds.2014.08.022"},{"key":"9913_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/MPG.0000000000000850","volume":"61","author":"A Assa","year":"2015","unstructured":"Assa A, Ish-Tov A, Rinawi F, Shamir R. School attendance in children with functional abdominal pain and inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2015;61:553\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9913_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jpeds.2015.07.058","volume":"167","author":"DR Hoekman","year":"2015","unstructured":"Hoekman DR, Rutten JM, Vlieger AM, Benninga MA, Dijkgraaf MG. Annual costs of care for pediatric irritable bowel syndrome, functional abdominal pain, and functional abdominal pain syndrome. J Pediatr. 2015;167:1103-8.e2.","journal-title":"J Pediatr"},{"key":"9913_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1088-145X.2003.00081.x","volume":"8","author":"M Jarrett","year":"2003","unstructured":"Jarrett M, Heitkemper M, Czyzewski DI, Shulman R. Recurrent abdominal pain in children: forerunner to adult irritable bowel syndrome? J Spec Pediatr Nurs. 2003;8:81\u20139.","journal-title":"J Spec Pediatr Nurs"},{"key":"9913_CR7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-042101","volume":"147","author":"R Rexwinkel","year":"2021","unstructured":"Rexwinkel R, de Bruijn CMA, Gordon M, Benninga MA, Tabbers MM. Pharmacologic treatment in functional abdominal pain disorders in children: a systematic review. Pediatrics. 2021;147:e2020042101.","journal-title":"Pediatrics"},{"key":"9913_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jpc.16323","volume":"59","author":"V Dipasquale","year":"2023","unstructured":"Dipasquale V, Palermo L, Barbalace A, Tumminello G, Romano C. Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders. J Paediatr Child Health. 2023;59:458\u201363.","journal-title":"J Paediatr Child Health"},{"key":"9913_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/ajg.2011.487","volume":"107","author":"AM Vlieger","year":"2012","unstructured":"Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol. 2012;107:627\u201331.","journal-title":"Am J Gastroenterol"},{"key":"9913_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/191026","volume":"2014","author":"Z Pourmoghaddas","year":"2014","unstructured":"Pourmoghaddas Z, Saneian H, Roohafza H, Gholamrezaei A. Mebeverine for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Biomed Res Int. 2014;2014:191026.","journal-title":"Biomed Res Int"},{"key":"9913_CR11","doi-asserted-by":"crossref","unstructured":"Fluer FS, Kudryavtseva AV, Titarev SI, Bykova IB, Bondarenko VM. A remedy for inhibiting the growth of Staphylococci, suppressing the Staphylococcal enterotoxins production and removing them from biological substrates. Zhurnal mikrobiologii, epidemiologii I immunobiologii (in Russian), 2017;\u2116 3:71\u201377.","DOI":"10.36233\/0372-9311-2017-3-71-77"},{"key":"9913_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42176-z","volume":"9","author":"CA Howell","year":"2019","unstructured":"Howell CA, Mikhalovsky SV, Markaryan EN, Khovanov AV. Investigation of the adsorption capacity of the enterosorbent Enterosgel\u00ae for a range of bacterial toxins, bile acids and pharmaceutical drugs. Sci Rep. 2019;9:5629.","journal-title":"Sci Rep"},{"key":"9913_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000287","volume":"6","author":"CA Howell","year":"2019","unstructured":"Howell CA, Markaryan E, Allgar V, Kemppinen A, Khovanov A, Pandya P, et al. Enterosgel for the treatment of adults with acute diarrhoea in a primary care setting: a randomised controlled trial. BMJ Open Gastroenterol. 2019;6:e000287.","journal-title":"BMJ Open Gastroenterol"},{"key":"9913_CR14","unstructured":"Ruzhentsova, TA, Gorelov AV, Ploskireva AA. Choice of an adequate therapy regimen for acute enteric infections in children: results of a randomized trial. Epidemiol Infect Dis. 2016;\u21164:70\u201374."},{"key":"9913_CR15","doi-asserted-by":"crossref","unstructured":"Markovinovi\u0107 L, Knezovi\u0107 I, Kniewald T, Stemberger Mari\u0107 L, Trkulja V, Te\u0161ovi\u0107 G. Enteroadsorbent Polymethylsiloxane Polyhydrate vs. Probiotic Lactobacillus reuteri DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized Controlled Trial. Front Pediatr. 2020;8:553960.","DOI":"10.3389\/fped.2020.553960"},{"key":"9913_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.553960","volume":"8","author":"L Markovinovi\u0107","year":"2020","unstructured":"Markovinovi\u0107 L, Knezovi\u0107 I, Kniewald T, Stemberger Mari\u0107 L, Trkulja V, Te\u0161ovi\u0107 G. Enteroadsorbent polymethylsiloxane polyhydrate vs. probiotic Lactobacillus reuteri DSM 17938 in the treatment of rotaviral gastroenteritis in infants and toddlers, a randomized controlled trial. Front Pediatr. 2020;8:553960.","journal-title":"Front Pediatr"},{"key":"9913_CR17","first-page":"31","volume":"N10","author":"DV Usenko","year":"2015","unstructured":"Usenko DV, Gorelov YA, Rudyk AV. Application of enterosorbents in the treatment of intestinal infections in children with concomitant atopic dermatitis. Pharmateca. 2015;N10:31\u20135.","journal-title":"Pharmateca"},{"issue":"5","key":"9913_CR18","first-page":"17","volume":"9","author":"AI Khavkin","year":"2020","unstructured":"Khavkin AI, Volynets GV. Polymethylsiloxane polyhydrate (Enterosgel\u00ae) in the complex treatment of diarrhea syndrome in children with diseases of the digestive system. EC Paediatrics. 2020;9(5):17\u201327.","journal-title":"EC Paediatrics"},{"key":"9913_CR19","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1136\/gutjnl-2022-327293","volume":"71","author":"CA Howell","year":"2022","unstructured":"Howell CA, Kemppinen A, Allgar V, Dodd M, Knowles CH, McLaughlin J, et al. Double-blinded randomised placebo controlled trial of Enterosgel\u00ae (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D). Gut. 2022;71:2430\u20138.","journal-title":"Gut"},{"key":"9913_CR20","unstructured":"Appendix A: Rome IV Diagnostic Criteria for FGIDs. https:\/\/theromefoundation.org\/rome-iv\/rome-iv-criteria\/. Accessed 31 Jul 2025."},{"key":"9913_CR21","first-page":"481","volume-title":"Sol-gel technology of the mesoporous methylsilicic acid hydrogel: medicine aspects of globular porous organosilicon materials application","author":"NI Yashina","year":"2008","unstructured":"Yashina NI, Plygan EP, Semenov VG, Martynenko AM, Glushchenko OV. Sol-gel methods for materials processing. In: Innocenzi P, Zub YL, Kessle VG, editors. Sol-gel technology of the mesoporous methylsilicic acid hydrogel: medicine aspects of globular porous organosilicon materials application. Dordrecht: Springer; 2008. p. 481\u20138."},{"key":"9913_CR22","volume-title":"Biodefence - advanced materials and methods for health protection","author":"V Nikolaev","year":"2011","unstructured":"Nikolaev V. Enterosgel: a novel organosilicon enterosorbent with a wide range of medical applications. In: Mikhalovsky S, Khajibaev A, editors. Biodefence - advanced materials and methods for health protection. Springer; 2011."},{"key":"9913_CR23","unstructured":"European Commission Directorate General for Health and Consumers. 2010. Guidelines on Medical Devices. MEDDEV 2.7\/3. December 2010. Available at: http:\/\/ec.europa.eu\/consumers\/sectors\/medical-devices\/files\/meddev\/2_7_3_en.pdf"},{"key":"9913_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.14309\/ajg.0000000000000589","volume":"115","author":"N Badihian","year":"2020","unstructured":"Badihian N, Yaghini O, Badihian S, Shahsanai A, Saneian H. Comparison of the efficacy of buspirone and placebo in childhood functional abdominal pain: a randomized clinical trial. Am J Gastroenterol. 2020;115:756\u201365.","journal-title":"Am J Gastroenterol"},{"key":"9913_CR25","first-page":"A20","volume":"12","author":"A Staunton","year":"2021","unstructured":"Staunton A, Golestaneh AK, Allen S, Nair MV. P16 Diagnosis and management of functional gastrointestinal disorders: a clinical audit. Frontline Gastroenterol. 2021;12:A20\u20131.","journal-title":"Frontline Gastroenterol"},{"key":"9913_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cpt1974155443","volume":"15","author":"DR Taves","year":"1974","unstructured":"Taves DR. Minimization: a new method of assigning subjects to treatment and control groups. Clin Pharmacol Ther. 1974;15:443\u201353.","journal-title":"Clin Pharmacol Ther"},{"key":"9913_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11136-014-0781-x","volume":"24","author":"JW Varni","year":"2015","unstructured":"Varni JW, Bendo CB, Denham J, Shulman RJ, Self MM, Neigut DA, et al. PedsQL\u2122 Gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls. Qual Life Res. 2015;24:363\u201378.","journal-title":"Qual Life Res"},{"key":"9913_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MPG.0000000000000414","volume":"59","author":"JW Varni","year":"2014","unstructured":"Varni JW, Bendo CB, Denham J, Shulman RJ, Self MM, Neigut DA, et al. PedsQL\u2122 Gastrointestinal symptoms module: feasibility, reliability, and validity. J Pediatr Gastroenterol Nutr. 2014;59:347\u201355.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9913_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/14737167.5.3.353","volume":"5","author":"U Ravens-Sieberer","year":"2005","unstructured":"Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, et al. KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert Rev Pharmacoecon Outcomes Res. 2005;5:353\u201364.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"9913_CR30","doi-asserted-by":"crossref","unstructured":"Ravens-Sieberer U, Herdman M, Devine J, Otto C, Bullinger M, Rose M et al. The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances. Qual Life Res 2014:23:791\u2013803. Gordon M, Benninga MA, Borlack R, Borrelli O, Chogle A, Darbari A et al. ESPGHAN and NASPGHAN 2023 protocol for paediatric FAPD treatment guidelines (standard operating procedure). BMJ Paediatr Open. 2023:7:e002166.","DOI":"10.1007\/s11136-013-0428-3"},{"key":"9913_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s11136-007-9240-2","volume":"16","author":"U Ravens-Sieberer","year":"2007","unstructured":"Ravens-Sieberer U, Auquier P, Erhart M, Gosch A, Rajmil L, Bruil J, et al. The KIDSCREEN-27 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Qual Life Res. 2007;16:1347\u201356.","journal-title":"Qual Life Res"},{"key":"9913_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.","journal-title":"BMC Med"},{"key":"9913_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpeds.2020.02.032","volume":"221","author":"J Zeevenhooven","year":"2020","unstructured":"Zeevenhooven J, Rexwinkel R, Van Berge VWA, et al. A Core Outcome Set for Clinical Trials in Pediatric Functional Abdominal Pain Disorders. J Pediatr. 2020;221:115\u201322.","journal-title":"J Pediatr"},{"key":"9913_CR34","unstructured":"Office for National Statistics (ONS). Internet access \u2013 households and individuals, Great Britain: 2020.\u00a0https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/householdcharacteristics\/homeinternetandsocialmediausage\/bulletins\/internetaccesshouseholdsandindividuals\/2020. Accessed 31Jul 2025."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09913-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09913-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:03:15Z","timestamp":1792587795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09913-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9913"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09913-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8076973\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was secured from the UK NHS Health Research Authority Health and Social Care Research Ethics Committee A (HSC REC A) on July 1\u2009st 2025 (reference number 25\/NI\/0085). Written informed consent will be obtained from young people aged 16\u201318 years and from parents\/guardians of younger children. Additionally, assent to participate in the study will be secured from younger children where possible and informed consent obtained from young people reaching the age of 16 years during the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate {30}","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.M. is the founder and director of the study Sponsor, Enteromed Ltd, which is the exclusive distributor of Enterosgel\u00ae in the UK. C.H. is employed by Enteromed Ltd. R.H. is employed by the funder Bioline Products s.r.o. S.A., M.N., M.A., C.S., D.B., M.D. declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests {7b}","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"618"}}